Literature DB >> 9590398

Dissolution of gallbladder stones with methyl tert-butyl ether and stone recurrence: a European survey.

A Hellstern1, U Leuschner, A Benjaminov, H Ackermann, T Heine, D Festi, M Orsini, E Roda, T C Northfield, R Jazrawi, W Kurtz, H J Schmeck-Lindenau, J Stumpf, B E Eidsvoll, E Aadland, G Lux, E Boehnke, D Wurbs, M Delhaye, M Cremer, I Sinn, E Höring, U v Gaisberg, M Neubrand, F Paul.   

Abstract

Since there are now several ways to treat symptomatic gallstone disease, one is able to select treatment on the basis of the patient's comfort, the practicability, effectiveness, and side effects of the technique, and the relative costs. In order to assess the present status of contact dissolution with methyl tert-butyl ether with regard to these aspects, the present enquiry reports the data of 21 European hospitals. Eight hundred three patients were selected for contact litholysis of cholesterol gallbladder stones using methyl tert-butyl ether. Percutaneous transhepatic puncture of the gallbladder was performed under x-ray or ultrasound guidance. Dissolution rate, side effects, and treatment times of 268 patients from one single center were compared to those of 535 patients from the other 20 centers. Two hundred sixty-four patients were followed for five years to assess stone recurrence. Physicians were asked how they assessed the expenditure of the method, the discomfort to the patients, and the staffing situation. Patients were asked to indicate their acceptance on an analog scale. Puncture was successful in 761 (94.8%) patients. Prophylactic administration of antibiotics was not necessary. Stones were dissolved in 724 (95.1%) patients. In 315 (43.5%) sludge remained in the gallbladder. The most severe complication was bile leakage, which led 12 (1.6%) patients to have elective cholecystectomy. Toxic injuries due to the ether were not reported. Method-related lethality amounted to 0%, 30-day-lethality to 0.4%. Stone recurrence rate was about 40% in solitary stones and about 70% in multiple stones over five years. Patients with multiple stones developed recurrent stones almost twice as often as those with solitary stones. The probability of stone recurrence in patients with sludge in the gallbladder after catheter removal was not statistically significantly different from those without sludge. Seventy to 90% of the centers found the puncture to be simple and not distressing for patients and the relation between expenditure and therapeutic success to be acceptable. The acceptance of contact litholysis by the patients was excellent. Contact litholysis when applied by an experienced team provides real advantages in the treatment of gallstone disease. The method is technically simple, well accepted by the patients, and can be easily applied in community hospitals. Contact litholysis may be of particular value in patients who are not suitable for anesthesia or surgery.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590398     DOI: 10.1023/a:1018811409538

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

1.  Gallstone dissolution in methyl tert-butyl ether after mechanical fragmentation: in vitro study.

Authors:  D S Lu; C S Ho; L C Allen
Journal:  AJR Am J Roentgenol       Date:  1990-07       Impact factor: 3.959

2.  Rapid dissolution of gallstones by methyl tert-butyl ether. Preliminary observations.

Authors:  M J Allen; T J Borody; T F Bugliosi; G R May; N F LaRusso; J L Thistle
Journal:  N Engl J Med       Date:  1985-01-24       Impact factor: 91.245

3.  Shock-wave lithotripsy of gallbladder stones. The first 175 patients.

Authors:  M Sackmann; M Delius; T Sauerbruch; J Holl; W Weber; E Ippisch; U Hagelauer; O Wess; W Hepp; W Brendel
Journal:  N Engl J Med       Date:  1988-02-18       Impact factor: 91.245

4.  Gall stone dissolution with methyl tert-butyl ether: how to avoid complications.

Authors:  A Hellstern; M Leuschner; H Frenk; H W Dillinger; W Caspary; U Leuschner
Journal:  Gut       Date:  1990-08       Impact factor: 23.059

5.  Gall stone recurrence and its prevention: the British/Belgian Gall Stone Study Group's post-dissolution trial.

Authors:  K A Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

6.  [Expected costs in the conservative and surgical treatment of uncomplicated cholecystolithiasis].

Authors:  A Sonnenberg; U Leuschner; M Leuschner
Journal:  Z Gastroenterol       Date:  1982-02       Impact factor: 2.000

7.  Early gallstone recurrence rate after successful shock-wave therapy.

Authors:  M Sackmann; E Ippisch; T Sauerbruch; J Holl; W Brendel; G Paumgartner
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

8.  Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment.

Authors:  N Villanova; F Bazzoli; F Taroni; R Frabboni; G Mazzella; D Festi; L Barbara; E Roda
Journal:  Gastroenterology       Date:  1989-09       Impact factor: 22.682

9.  Teratology evaluation of methyl tertiary butyl ether in rats and mice.

Authors:  C C Conaway; R E Schroeder; N K Snyder
Journal:  J Toxicol Environ Health       Date:  1985

10.  Biochemical effects of methyl tertiary-butyl ether in extended vapour exposure of rats.

Authors:  H Savolainen; P Pfäffli; E Elovaara
Journal:  Arch Toxicol       Date:  1985-09       Impact factor: 5.153

View more
  10 in total

Review 1.  Fortnightly review: gallbladder disease.

Authors:  M C Bateson
Journal:  BMJ       Date:  1999-06-26

2.  Gallstones.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-04

3.  Methyl tert butyl ether is anti-angiogenic in both in vitro and in vivo mammalian model systems.

Authors:  John Kozlosky; Josephine Bonventre; Keith Cooper
Journal:  J Appl Toxicol       Date:  2012-03-08       Impact factor: 3.446

4.  Arachidyl amido cholanoic acid (Aramchol) is a cholesterol solubilizer and prevents the formation of cholesterol gallstones in inbred mice.

Authors:  T Gilat; A Leikin-Frenkel; L Goldiner; H Laufer; Z Halpern; F M Konikoff
Journal:  Lipids       Date:  2001-10       Impact factor: 1.880

Review 5.  [Acute biliary colic. Etiology, diagnosis and therapy].

Authors:  Birgit Terjung; M Neubrand; T Sauerbruch
Journal:  Internist (Berl)       Date:  2003-05       Impact factor: 0.743

Review 6.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

Review 7.  Cholecystectomy versus no cholecystectomy in patients with silent gallstones.

Authors:  K S Gurusamy; K Samraj
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

8.  Efficacy and safety of a novel topical agent for gallstone dissolution: 2-methoxy-6-methylpyridine.

Authors:  Ho Joong Choi; Suk Joon Cho; Ok-Hee Kim; Jin Sook Song; Ha-Eun Hong; Sang Chul Lee; Kee-Hwan Kim; Sang Kuon Lee; Young Kyoung You; Tae Ho Hong; Eun Young Kim; Jung Hyun Park; Gun Hyung Na; Dong Do You; Jae Hyun Han; Jae Woo Park; Bong Jun Kwak; Tae Yun Lee; Joseph Ahn; Hwan Hee Lee; Seung Kyu Kang; Kyu-Seok Hwang; Jae-Kyung Jung; Kwan-Young Jung; Say-June Kim
Journal:  J Transl Med       Date:  2019-06-10       Impact factor: 5.531

9.  Use of Methyl Tert-Butyl Ether for the Treatment of Refractory Intrahepatic Biliary Strictures and Bile Casts: A Modern Perspective.

Authors:  Gregory Kim; Saninuj N Malayaman; Michael Stuart Green
Journal:  Case Rep Surg       Date:  2015-07-07

10.  Superior gallstone dissolubility and safety of tert-amyl ethyl ether over methyl-tertiary butyl ether.

Authors:  Dong Do You; Suk Joon Cho; Ok-Hee Kim; Jin Sook Song; Kyu-Seok Hwang; Sang Chul Lee; Kee-Hwan Kim; Ho Joong Choi; Ha-Eun Hong; Haeyeon Seo; Tae Ho Hong; Jung Hyun Park; Tae Yoon Lee; Joseph Ahn; Jae-Kyung Jung; Kwan-Young Jung; Say-June Kim
Journal:  World J Gastroenterol       Date:  2019-10-21       Impact factor: 5.742

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.